Ropivacaine 7.5mg/Ml Solution For Injection
Out of date information, search anotherRopivacaine 2mg/ml, 7.5mg/ml and 10mg/ml Solution for Injection
Ropivacaine Hydrochloride
Read all of this leaflet carefully before
you start using this medicine.
• Keep this leaflet. You may need to read it again
• If you any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
• If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
• The full name of this medicine is Ropivacaine 2mg/ml, 7.5mg/ml and 10mg/ ml Solution for Injection but within the leaflet it will be referred to as Ropivacaine solution.
In this leaflet:
j What Ropivacaine solution is and what it is used for
^ Before Ropivacaine solution is given to you
^ How Ropivacaine solution is given to you ^ Possible side effects ^ How to store 6| Further information
j What Ropivacaine solution is and what it is used for
Ropivacaine solution contains the active substance ropivacaine hydrochloride which is a type of medicine called local anaesthetic. These are chemical substances that are used to numb an area of the body.
Ropivacaine solution 7.5 mg/ml & 10 mg/ml solution for injection is used in:
Ropivacaine solution is used in adults and children above 12 years to numb (anaesthetise) parts of the body. It is used to stop pain happening or to provide pain relief. It can be used to:
• Numb parts of the body during surgery, including having a baby by Caesarean section.
• Relieve pain during childbirth, after surgery, or after an accident.
Ropivacaine solution 2 mg/ml solution for injection is used in:
• Ropivacaine solution is used in adults and children of all ages for acute pain management. It numbs (anaesthetises) parts of the body e.g. after surgery.
^ Before Ropivacaine solution is given to you
You must not be given Ropivacaine solution:
• If you are allergic (hypersensitive) to ropivacaine hydrochloride or to any of the other ingredients of Ropivacaine solution.
• If you have an existing allergy to any other local anesthetic of the amide-type, such as bupivacaine or lidocaine.
• If you have a decreased volume of blood in your bloodstream (hypovolemia).
• Ropivacaine solution must not be injected into a blood vessel, or into the neck of the womb to relieve pain during childbirth.
If you are not sure if any of the above applies to you, talk to your doctor before you are given Ropivacaine solution.
Take special care with Ropivacaine solution:
• If you suffer from problems with your heart, liver or kidney. If so, tell your doctor, because he might need to adjust the does of Ropivacaine solution.
• If you or anyone in your family has ever been told that you have a rare disease of the blood pigment (porphyria). If so, tell your doctor because he may need to give you another anesthetic medicine.
• Before treatment with Ropivacaine solution, tell your doctor about any diseases or medical conditions that you have.
• Ropivacaine Solution 7.5mg/ml & 10mg/ml in children up to and including 12 years. Other strengths (2 mg/ml, 5 mg/ml) may be more appropriate.
Take special care with Ropivacaine Solution 2 mg/ml solution for injection:
• In newborn children as they are more susceptible to Ropivacaine Solution.
• In children < 12 years as some injections of Ropivacaine Solution in order to numb parts of the body are not established in younger children.
Taking/ Using other medicines
Please tell your doctor if you are taking/using or have recently taken/used any other medicines, including medicines obtained without a prescription and herbal medicines.
Ropivacaine solution should only be used with caution if you are taking / receiving:
• other anesthetics
• medicines that are used for treatment of heart rhythm disturbances (antiarrhythmics)
• strong pain relievers (opioids)
The simultaneous use of Ropivacaine solution and one of the above mentioned medicines can strengthen their respective effects and side effects.
Prolonged use of ropivacaine should be avoided if you are receiving/taking:
• medicines for depression (e.g.fluvoxamine) or
• antibiotics for the treatment of bacterial infections (e.g. enoxacin)
Your body takes longer to get rid of Ropivacaine solution if you are taking one of these medicines.
Pregnancy and breast-feeding
Before you are given Ropivacaine solution, tell your doctor if you are pregnant, if you intend to become pregnant or if you are breast-feeding. It is unknown if ropivacaine influences pregnancy or passes into human breast milk. Ask your doctor or pharmacist for advice before taking any medicine if you are pregnant or breast-feeding.
Driving and using machines
No studies on the effects on the ability to drive and use machines have been performed. However, a slight effect on mental functions and coordination can be expected, depending on the dose. Motoricity and reaction speed may be temporarily impaired, even if there are no other clear signs of poisoning of the central nervous system (central nervous system toxicity). You should not drive or use tools or machines after you have been given Ropivacaine solution until the next day.
Important information about some of the ingredients of Ropivacaine solution:
Ropivacaine 2mg/ml Solution for Injection:1ml contains 3.6mg sodium.
Ropivacaine 7.5mg/ml Solution for Injection:1ml contains 3.0mg sodium.
Ropivacaine 10mg/ml Solution for Injection:1ml contains 2.9mg sodium.
You have to take this into consideration if you are on a controlled sodium diet.
Continued on next page
Continued on top of next column AAAD9333
The following information is intended for medical or healthcare professionals only.
Ropivacaine 2mg/ml, 7.5mg/ml and 10mg/ml Solution for Injection
Ropivacaine Hydrochloride
Handling
The medicinal product should be visually examined before use. The solution should only be used if it is clear and practically free from particulate matter and if the container is undamaged.
The intact container must not be re-autoclaved. Container in sterile pouch should be chosen when a sterile outside is required.
Posology
See the Summary of Product Characteristics for information on posology.
Method of administration
Perineural and epidural administration via injection or infusion.
Ropivacaine solution should only be used by, or under the supervision of, clinicians experienced in regional anaesthesia.
May not be administered in intravenous regional anaesthesia or in obstertric paracervical anaesthesia.
Continued on next page
Continued on top of next column AAAD9333
|
Ropivacaine 2mg/ml, 7.5mg/ml and 10mg/ml Solution for Injection PIL - UK |
colours/plates: | ||
|
1. Black | |||
|
^actavis creating value In pharmaceutical! t 00441271 311400 f 00441271 311449 |
item no: AAAD9333 |
dimensions: 160x460 |
2. |
|
print proof no: 4 |
pharmacode: |
3. | |
|
4. | |||
|
origination date: 19/06/12 |
min pt size: |
5. | |
|
originated by: C.Paull |
6. | ||
|
approved for print/date |
revision date: 05-07-12 |
Technical Approval |
Non Printing Colours |
|
1. | |||
|
revised by: BW |
date sent: 16/06/12 (resent 05-07-12 BW) | ||
|
2. | |||
|
supplier: Holopack |
technically app. date: 05-07-12 BW |
3. | |
3| How Ropivacaine solution is given to you
Ropivacaine solution is given to you by a doctor. The dose that you receive depends on your body size, age, physical condition and on which kind of pain relief you need.
You will receive Ropivacaine solution as an injection. It will be injected by your doctor in one of the following places:
• the body part that needs to be numbed
• near the body part that has to be numbed or
• in an area away from the part of the body that needs to be numbed, for example if you are given an epidural injection (into the area around the spinal cord).
After the administration you won't feel pain, heat or cold in the numbed area, but you are still able to feel pressure and touch.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
If you you have been given too much Ropivacaine solution
Serious side effects caused by an administration of too much Ropivacaine solution needs special treatment and the doctor treating you is trained to handle such situations (see section 4 for possible side effects related to overdose).
^ Possible side effects
Like all medicines, ropivacaine can cause side effects, although not everybody gets them. Important side effects to pay attention to:
Allergic reactions in a life threatening occurrence, such as anaphylaxis are rare (affecting less than 1 in 1000 people). Possible symptoms to look out for, are swelling of the face, lips, tongue or other parts of the body, breathlessness, wheezing or difficult breathing. Tell your doctor immediately, if you think that Ropivacaine solution is causing an allergic reaction.
Other possible side effects
Very common (affects more than 1 user in 10):
• Low blood pressure (hypotension)
• Feeling sick (nausea)
Common (affects less than 1 in 10 people):
• Pins and needles
• Dizziness
• Headache
• Slow or fast heart beat (bradycardia, tachycardia)
• High blood pressure (hypertension)
• Being sick (vomiting)
• Difficulty in passing urine
• High temperature (fever) or stiffness (rigor)
• Back pain
Uncommon (affects less than 1 in 100 people):
• Anxiety
• Decreased sensitivity or feeling in the skin
• Fainting
• Difficulty with breathing
• Low body temperature (hypothermia)
• Some symptoms can happen if the injection was given into a blood vessel by a mistake, or if you have been given too much Ropivacaine solution (see also "If you have been given too much Ropivacaine solution"). These include fits (seizures), numbness, tingling or pins and needles, feeling dizzy or light-headed, numbness of lips and around the mouth, numbness of the tonge, visual and auditory disturbances, problems with your speech, stiff muscles and trembling.
Rare (affects less than 1 in 1000 people):
• Heart attack (cardiac arrest)
• Uneven heart beat (arrhythmias)
• Itchy skin rash
Other possible side effects
• Numbness, due to nerve irritation caused ny the needle or the injection. This usually does not last for long.
The first signs of an overdose of Ropivcaine solution are:
• dizziness or light headedness,
• visual or auditory disturbances,
• numbness of the lips and around the mouth,
• numbness of the tongue.
Continued on top of next column AAAD9333
______
Tell your doctor immediately, if any of these symptoms happen to you or when you think that you received too much of Ropivcaine solution. He will stop giving you Ropivcaine solution to reduce the risk of serious side effects.
Further serious side effects caused by too high doses of Ropivcaine solution are problems with speech, tingling, tremor, twitching of your muscles, fits (seizures) and loss of consciousness.
Possible side effects of other local anaesthetics which might also be caused by Ropivacaine solution
• Rare (affecting less than 1 in 1000 people): damaged nerves. This may cause permanent problems.
• The whole body may get numbed (anesthesised), if too much ropivacaine is injected into the spinal fluid.
Children
In children, the side effects are the same as in adults except for low blood pressure which happens less often in children (affecting less than 1 in 10 children) and being sick which happens more often in children (affecting more than 1 in 10 children)
If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor.
^ How to store
Keep out of the reach and sight of children.
Do not use Ropivacaine solution after the expiry date which is stated on the pack.
Do not freeze.
Do not store above 30°C.
In-use shelf-life:
From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2-8 °C.
Usually Ropivacaine solution is stored in pharmacies and hospitals. If this medicinal product is not used immediately, the responsibility for its storage lies with the doctors. They are also responsible for the correct disposal. Residues of this medicinal product and all equipment used in its reconstitution, dilution, and administration must be destroyed in accordance with the hospital's standard procedures, with due observation of legal regulations for disposal of hazardous waste
^ Further information
What Ropivacaine solution contains
The active substance is ropivacaine hydrochloride. Ropivacaine 2mg/ml Solution for Injection:! ml
contains 2.12mg ropivacaine hydrochloride monohydrate, equivalent to 2mg of ropivacaine hydrochloride.
Ropivacaine 7.5mg/ml Solution for Injection: 1 ml
contains 7.94mg ropivacaine hydrochloride monohydrate, equivalent to 7.5mg of ropivacaine hydrochloride.
Ropivacaine 10mg/ml Solution for Injection: 1 ml
contains 10.58mg ropivacaine hydrochloride monohydrate, equivalent to 10mg of ropivacaine hydrochloride.
The other ingredients are sodium chloride, sodium hydroxide (for pH adjustment), hydrochloric acid (3.6%) (for pH adjustment) and water for injection.
What Ropivacaine solution looks like and contents of the pack
Ropivacaine solution is a clear, colourless solution for injection.
Ropivacaine solution is in plastic ampoules (PP) which are packed in sterile blister pouches or see through pouches.
Pack-size:
5 x 10ml plastic ampoules
Marketing Authorisation Holder
Actavis Group PTC ehf, Reykjavikurvegi 76-78, Hafnarfjordur, Iceland
Manufacturers:
Actavis Nordic A/S, Ornesgardsvej 16, 2820 Gentofte, Denmark
Actavis Deutschland GmbH & Co.KG Wi lly-Bran dt-A l lee 2, 81829 Munchen Germany
This leaflet was last revised in June 2012
^actavis
Actavis, Barnstaple, EX32 8NS, UK
Careful aspiration before and during injection is recommended to prevent intravascular injection. The patient's vital functions should be observed closely during the injection. If toxic symptoms occur, the injection should be stopped immediately. Fractionation of the calculated local anaesthetic dose is recommended, whatever rout of administration.
Treatment of acute toxicity
Equipment and drugs necessary for monitoring and emergency resuscitation should be immediately available. If signs of acute systemic toxicity appear, injection of the local anaesthetic should be stopped immediately. See the Summary of Product Characteristics for further information on treatment.
Incompatibilities
This medicinal product must not be mixed with other medical products. In alkaline solution precipitation may occur as ropivacaine shows poor solubility at pH>6.
Shelf-life and storage
Ropivacaine solution contains no preservatives. For single use only. Discard any unused solutions in line with standard procedure for disposal of hazardous waste.
Continued on top of next column AAAD9333
^actavis
Actavis, Barnstaple, EX32 8NS, UK
|
Ropivacaine 2mg/ml, 7.5mg/ml and 10mg/ml Solution for Injection PIL - UK |
colours/plates: | ||
|
1. Black | |||
|
^actavis creating value In pharmaceutical! t 00441271 311400 f 00441271 311449 |
item no: AAAD9333 |
dimensions: 160x460 |
2. |
|
print proof no: 4 |
pharmacode: |
3. | |
|
4. | |||
|
origination date: 19/06/12 |
min pt size: |
5. | |
|
originated by: C.Paull |
6. | ||
|
approved for print/date |
revision date: 05-07-12 |
Technical Approval |
Non Printing Colours |
|
1. | |||
|
revised by: BW |
date sent: 16/06/12 (resent 05-07-12 BW) | ||
|
2. | |||
|
supplier: Holopack |
technically app. date: 05-07-12 BW |
3. | |